- LPAR1 Inhibitor. Medical application and preparation method thereof
-
LPAR1 Inhibitor, medical application and preparation method thereof, and the structural general formula I of the inhibitor is as follows. In-flight RX Alkyl groups selected from H, C1 - C6, COOCH3 , CF3 , NO2 ,
- -
-
Paragraph 0072-0074; 0085-0086; 0089-0090
(2021/10/05)
-
- benzamide derivatives as oxytocin agonists and vasopressin antagonists
-
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or Via receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
- -
-
-